<DOC>
	<DOCNO>NCT01067105</DOCNO>
	<brief_summary>6-month safety extension study subject complete Study 060-633 ( NCT00953147 ) . Evaluating long-term safety ciclesonide HFA nasal aerosol 160 μg administer once-daily patient Perennial Allergic Rhinitis .</brief_summary>
	<brief_title>A 6 Month Study Once Daily Ciclesonide Hydrofluoroalkane ( HFA ) Nasal Aerosol The Treatment Perennial Allergic Rhinitis ( PAR ) Subjects 12 Years Older</brief_title>
	<detailed_description>This 6-month multi-center , open-label , long-term safety extension study subject complete Study 060-633 ( NCT00953147 ) . This study design evaluate long-term safety ciclesonide HFA nasal aerosol 160 μg administer once-daily male female subject 12 year old diagnose perennial allergic rhinitis ( PAR ) . This study previously post Sepracor Inc . In October 2009 , Sepracor Inc. acquire Dainippon Sumitomo Pharma. , October 2010 , Sepracor Inc 's name change Sunovion Pharmaceuticals Inc .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Subject successfully complete visit Study 060633 . Subject give write informed consent assent , include privacy authorization well adherence concomitant medication withhold period , prior participation . Subject male female 12 year old . Subject must general good health ( define absence clinically relevant abnormality determine Investigator ) base screen physical examination , clinical laboratory test , medical history . Subject , female 65 year age young , must negative urine pregnancy test ( perform Visit 1 ) . Females childbearing potential must instruct agree avoid pregnancy study must use acceptable method birth control : 1 . An oral contraceptive , intrauterine device ( IUD ) , implantable contraceptive , transdermal injectable contraceptive least 1 month prior enter study continue use throughout study thirty day follow study participation . 2 . Barrier method contraception , eg , condom and/or diaphragm spermicide participate study . 3 . Abstinence . Female subject pregnant lactating . History physical finding nasal pathology , include nasal polyp . Subject condition , judgment investigator , would preclude subject complete study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Perennial allergic rhinitis</keyword>
	<keyword>allergic rhinitis</keyword>
	<keyword>ciclesonide</keyword>
</DOC>